HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive... ( PARIS and MORRISTOWN N.J. Sept. 17 /-...)

HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada

Date:9/17/2010

PARIS and MORRISTOWN, N.J., Sept. 17 /PRNewswire-FirstCall/ -- HRA Pharma, a privately-held, European pharmaceutical company that develops healthcare solutions in reproductive health and endocrinology and makes them available worldwide, and Watson Pharmaceuticals, Inc. (NYSE: WPI) announced today that they have entered into a licensing agreement for the commercialization of HRA Pharma's next generation emergency contraceptive ulipristal acetate in Canada.

This agreement marks the next step for the commercialization of ulipristal acetate in North America and the second collaboration between the two companies in the field of reproductive health. Recently, the U.S. Food and Drug Administration (FDA) approved ulipristal acetate, which Watson will market in the U.S. under the name ella®, as a prescription-only emergency contraceptive. HRA Pharma plans to file a New Drug Submission for ulipristal acetate with Health Canada before the end of 2010. If approved, Watson will be responsible for marketing and commercialization of ulipristal acetate in Canada.

"HRA Pharma strives to improve reproductive health with products and services that are accessible to women worldwide, and Watson continues to share this mission with us," said Dr. Erin Gainer, CEO, HRA Pharma. "We are excited to expand our partnership with Watson for ulipristal acetate into Canada. Our two companies share the commitment to making emergency contraception with ulipristal acetate available to women across North America."

"As Watson continues to prepare for the fourth quarter 2010 launch of the ella® (ulipristal acetate) emergency contraceptive in the U.S., we are pleased that if approved in Canada, Watson will be responsible for bringing this important emergency contraceptive
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.; HRA Pharma
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Pharmasset to Present at the UBS Global Life Sciences Conference
2. Assured Pharmacy Reports Same Store Sales for the Month of August 2010
3. National Institutes of Health Chooses ScriptPro for Pharmacy Automation
4. Onyx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
5. LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
6. PDL BioPharma Announces Retirement of $54.3 Million of 2.75% Convertible Notes Due 2023
7. ISTA Pharmaceuticals Initiates Phase 3 Clinical Program for REMURA™ in Dry Eye Disease
8. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
9. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
10. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of Eddie Munson to Board of Directors
11. FierceBiotech Names VentiRx Pharmaceuticals as One of the Fierce 15 Biotech Companies of 2010

Post Your Comments:

(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... Annual Healthcare Conference on Thursday, May 30, 2013, at ... beginning at 9:20 a.m. Eastern Daylight Time. Arvind ... will present at the conference. Live audio of the presentation ... www.amgen.com , under Investors. A replay of the webcast ...

(Date:5/23/2013)... , May 23, 2013 A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...

(Date:5/23/2013)... May 23, 2013 Anthem Blue Cross patients ... have required them to obtain their medications by mail ... and Whatley Kallas LLC. The lawsuit, ... that Blue Cross,s mandatory mail order program announced late ... and privacy. "This settlement brings to a ...

Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2 First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3 Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2 Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3

[0] Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference [0] First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams [0] Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog

... November 4, 2010 ... ... --> ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r in ...

... (OTCQB: CGCP), a leading developer of surgical products used ... reported financial results for its third quarter and first ... for the third quarter of 2010 was $2,764,000, a ... $2,134,000. Gross margin was 84% for the quarter, two ...

Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development Cardiogenesis Reports Third Quarter 2010 Results

(Date:5/25/2013)... Many viruses and parasites that affect both dogs and ... illness than can result in liver or kidney failure ... a veterinarian. These germs could be found ... Dr. Susan Nelson, a clinical associate professor at Kansas ... diseases can be fatal, even with treatment," she said ...

(Date:5/25/2013)... TX (PRWEB) May 25, 2013 Studies ... those who are carrying excessive weight and their inability ... for many, simply losing weight can naturally relieve many ... found that improvement in sleep quality was significantly associated ... six month study dated November 6th, 2012, ...

(Date:5/25/2013)... York, New York (PRWEB) May 25, 2013 ... who allegedly suffered serious, life-threatening episodes of internal bleeding while ... litigation underway in U.S. District Court, Southern District of Illinois, ... the Court’s website, 818 Pradaxa side effect claims had ... 2013. That’s up from 705 claims reported by the ...

(Date:5/25/2013)... (PRWEB) May 25, 2013 According ... Emergency Management Market, 2013–2018", published by MarketsandMarkets is ... a CARC of 5.54% which analyzes and studies ... North America, Europe, Asia, and Rest of the ... Market Data Tables , 87 Figures ...

(Date:5/25/2013)... 25, 2013 Acuity Games ’ innovative ... version of Word Hunt is available today, expanding ... Edge Match, Flash 2, Sudoku and Matchematics will roll out ... gameplay and revolutionary lifetime brain fitness measurement have been re-optimized ... “100 years of brain fitness measurement in your pocket. ...

Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2 Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2 Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4 Health News:Acuity Games Apps Come to the iPhone 2

[0] Hidden Dangers Dog Dog Parks [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep [0] Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports [0] Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets [0] Acuity Games Apps Come to the iPhone

... President,and CEO of America,s Health Insurance Plans, today ... ), "Today,s announcement presents an opportunity to ... rising health care costs in America., "At ... soar above inflation,every year, health insurance plans, tools ...

... Parenthood TV Ad For Containing,Inappropriate, Content While Original ... 13 "It is outrageous that,YouTube would black-out ... sex video while it continues to carry the ... of American Life League., The "inappropriate nature" ...

... replicated in larger study, experts caution , , WEDNESDAY, Feb. ... combat cancer that is now being used to treat ... also work against a common form of multiple sclerosis. ... issue of the New England Journal of Medicine ...

... SEGUNDO, Calif., Feb. 13 DaVita Inc.,(NYSE: DVA ... ended December,31, 2007. Net income for the three months ... share, as compared to $74.1 million, or $0.70 per,share, ... http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ), Net income for the year ended ...

... Eight outstanding cancer care providers from a variety of ... 2008 American Cancer Society Lane W. Adams Quality of ... The Lane W. Adams Quality of Life Award recognizes ... and consistent excellence in providing compassionate, skilled care, and ...

... COEUR D,ALENE, Idaho, Feb. 13 NightHawk,Radiology Holdings, Inc. (Nasdaq: ... groups across the United States, today announced,financial results for its ... 2007 Highlights, -- Full year revenues grew 65% to ... the full-year 2006. Organic revenue grew $21.4 million, or 23% ...

AHIP Statement on New York Attorney General's Announcement ICYMI: YouTube Censors American Life League Cancer Drug Works Against MS in Early Trial DaVita 4th Quarter 2007 Results American Cancer Society honors exemplary cancer caregivers NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Isopropanol (Includes Acetone)Isofedrol Isoenzymes, Amylase Islet Cell Antigen (ICA) 512